Atypical neuroleptic malignant syndrome responsive to conservative management.
暂无分享，去创建一个
[1] J. Levenson. Neuroleptic malignant syndrome. , 2007, The American journal of psychiatry.
[2] M. Goulon,et al. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. , 1983, Neurology.
[3] R. Stewart,et al. Neuroleptic malignant syndrome: response to dantrolene sodium. , 1983, Annals of internal medicine.
[4] J. Fermaglich,et al. Neuroleptic malignant syndrome. Successful treatment with bromocriptine. , 1983, JAMA.
[5] J. Delacour,et al. TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENE , 1982, The Lancet.
[6] R. Marshall,et al. TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENE SODIUM , 1982, The American journal of psychiatry.
[7] D. Weinberger,et al. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol. , 1977, The Journal of nervous and mental disease.
[8] J. Alpert,et al. Sudden catatonic stupor with disastrous outcome. , 1977, JAMA.
[9] D. Reimer,et al. Heat dyscontrol syndrome in patients receiving antipsychotic, antidepressant and antiparkinson drug therapy. , 1974, The Journal of the Florida Medical Association.
[10] M. Mandel,et al. Catatonic behavior, viral encephalopathy, and death. The problem of fatal catatonia. , 1972, Archives of general psychiatry.
[11] R. Allan,et al. Side effects of parenteral long-acting phenothiazines. , 1972, British medical journal.